Temperature Controlled Pharmaceutical Packaging Solutions Market Size 2025-2029
The temperature controlled pharmaceutical packaging solutions market size is forecast to increase by USD 5.9 billion, at a CAGR of 12.7% between 2024 and 2029.
The global temperature controlled pharmaceutical packaging solutions market is shaped by the need for advanced pharmaceutical packaging to protect sensitive products. Demand for reefer containers for temperature-sensitive pharmaceuticals is a key driver, as these units ensure product stability. This aligns with a focus on biopharma cold chain packaging market advancements, where both active and passive packaging systems play crucial roles. Concurrently, companies are pursuing strategic acquisitions to broaden their product portfolios and geographic reach, enhancing their ability to serve a wider customer base within the life sciences sector. Such moves indicate a maturing market where scale and comprehensive offerings are becoming critical differentiators for participants.A significant challenge to market expansion is the inadequate cold chain infrastructure and low adoption of automated technologies in certain developing economies. This deficiency can compromise supply chain integrity, as it increases the risk of temperature excursions that damage sensitive products like biologics and vaccines. The lack of trained personnel and reliable power supplies further compounds this issue, constraining the deployment of sophisticated smart packaging solutions. These functional barriers in cold chain logistics increase operational costs and limit the ability of service providers to meet the stringent demands of the pharmaceutical industry, thereby restricting market growth in affected regions.
What will be the Size of the Temperature Controlled Pharmaceutical Packaging Solutions Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The global temperature controlled pharmaceutical packaging solutions market is defined by the critical need for supply chain integrity. Innovations in passive packaging systems and active packaging systems are central to meeting the demands of transporting temperature-sensitive pharmaceuticals. The adoption of validated packaging solutions is driven by stringent good distribution practices. This ensures that biologic drug stability is maintained across the entire distribution network, from manufacturing facilities to the final point of care, mitigating risks associated with temperature excursions.Advancements in the biopharma cold chain packaging market are shaping logistics for high-value treatments. Solutions for cell and gene therapy transport often require cryogenic shipping and ultra-low temperature storage capabilities. Concurrently, there is a growing emphasis on sustainable and reusable packaging solutions to reduce environmental impact. The integration of smart packaging, including real-time temperature monitoring and data loggers, is becoming standard for ensuring traceability and compliance throughout the pharmaceutical supply chain, especially in clinical trial logistics and direct-to-patient shipping models.
How is this Temperature Controlled Pharmaceutical Packaging Solutions Industry segmented?
The temperature controlled pharmaceutical packaging solutions industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Product
- Type
- Passive systems
- Active systems
- End-user
- Pharmaceuticals
- Vaccines and biologics
- Others
- Geography
- North America
- Europe
- APAC
- South America
- Middle East and Africa
- Rest of World (ROW)
By Product Insights
The frozen segment is estimated to witness significant growth during the forecast period.
The frozen segment is centered on maintaining product stability in sub-zero environments, which is crucial for specialized therapies and biologics. This segment focuses on advanced insulation, active temperature regulation, and adherence to evolving regulatory standards for cold chain logistics. Innovations in phase change materials with consistent freezing profiles are utilized to minimize temperature excursions and preserve the integrity of high-value formulations. In 2023, this segment accounted for approximately 46.3% of the total market, highlighting its significance.
Operational priorities in this segment also include enhanced validation, monitoring, and traceability. The integration of real-time data logging and remote temperature tracking is becoming standard to improve transparency and control. Packaging designs are engineered to mitigate the impact of transit delays and climatic variations, ensuring the reliability of frozen pharmaceutical distribution. As the pharmaceutical sector expands into new markets, the demand for robust frozen packaging solutions that support precise, compliant delivery is expected to continue growing, making it a vital component of the industry.
Request Free Sample
The Frozen segment was valued at USD 2.0 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 32.9% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
The temperature controlled pharmaceutical packaging solutions market in North America is expanding, driven by the robust cold chain logistics sector, particularly in the United States. The region's advanced healthcare industry and the high volume of new drug approvals contribute to a strong demand for reliable packaging solutions. The US market alone constitutes over 85.1% of the North American market, underscoring its dominance. The presence of key logistics service providers intensifies competition and fosters innovation, further strengthening the market's growth trajectory in North America.
Excellent connectivity between the US, Canada, and Mexico creates significant opportunities for market players to expand their operations across North America. The rising pharmaceutical expenditure in neighboring countries supports this expansion. Developments in the pharmaceutical sector, including a growing number of clinical trials, necessitate strategic collaborations between drug developers and specialized logistics providers. These partnerships are crucial for managing and transporting temperature-sensitive materials, driving sustained demand for advanced temperature controlled packaging throughout the North America region.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global distribution of temperature-sensitive drugs demands robust solutions for protecting sensitive drugs during transport and ensuring biopharmaceutical cold chain integrity. A critical decision involves the choice between active vs passive temperature control systems, with the latter often using advanced thermal insulation for shippers and phase change materials for stable temperatures. Adherence to stringent regulatory standards for pharma shipping necessitates the thorough validation of pharmaceutical shipping containers. The specialized segment of temperature controlled packaging for biologics is a key growth driver, where managing temperature excursions in transit is paramount. This is supported by comprehensive temperature data logging in pharma logistics and the adoption of smart packaging for temperature monitoring to provide real-time oversight.From large-scale insulated containers for vaccine distribution to the highly specialized requirements of cryogenic logistics for cell therapies, the market is diversifying. Stakeholders are leveraging the cost-efficiency of passive packaging systems while also optimizing payload in thermal containers. A significant industry trend involves the adoption of sustainable materials in cold chain packaging and the expansion of reusable cold chain packaging solutions to reduce environmental impact. This evolution addresses emerging models like packaging solutions for direct-to-patient trials, which introduces complex last-mile cold chain delivery challenges that require innovative strategies to maintain product efficacy and safety through to the final destination.
What are the key market drivers leading to the rise in the adoption of Temperature Controlled Pharmaceutical Packaging Solutions Industry?
- The primary driver for the market is the growing demand for reefer containers within the pharmaceutical industry to transport temperature-sensitive products.
The increasing use of reefer containers for transporting temperature-sensitive pharmaceuticals is a significant factor driving market expansion. These containers are essential for maintaining the physical and chemical stability of products that require a controlled environment during transit. The logistical complexity of moving these goods necessitates a high degree of coordination to prevent spoilage. As a result, investments are being made to expand the global fleet of refrigerated containers, including those with advanced controlled-atmosphere technology. This expansion directly supports the adoption of sophisticated temperature controlled packaging, ensuring product integrity throughout the supply chain and meeting the stringent demands of the pharmaceutical industry.The growth in refrigerated warehouse capacity is another key dynamic supporting the market. These facilities are crucial nodes in the cold chain, providing the necessary infrastructure for storing temperature-sensitive pharmaceuticals before and during transit. An increase in the number of such warehouses enhances the overall resilience and efficiency of the supply chain, reducing the risk of temperature excursions. This expansion is driven by the rising global demand for pharmaceuticals, which require controlled storage environments. A well-developed network of refrigerated warehouses enables more effective management of inventory and facilitates the seamless distribution of products, thereby bolstering the demand for reliable packaging solutions.
What are the market trends shaping the Temperature Controlled Pharmaceutical Packaging Solutions Industry?
- A key upcoming trend is the increasing focus on traditional growth strategies, such as acquisitions, by companies in the market to expand their capabilities and market presence.
Strategic acquisitions are becoming a prevalent trend as companies seek to consolidate their market position and enhance their service offerings. In a moderately competitive landscape, participants are acquiring specialized firms to expand their product portfolios, gain access to new technologies, and broaden their geographic footprint. For example, a global provider of temperature-controlled shipping solutions recently acquired a manufacturer of passive packaging to strengthen its presence in key regional markets. This strategy allows companies to serve a wider customer base in the life sciences sector, providing more comprehensive solutions for the biopharma cold chain packaging market and driving revenue growth through expanded capabilities.The market is also characterized by a consistent introduction of new temperature-controlled pharmaceutical packaging products. Companies are innovating to meet the evolving demands of the pharmaceutical industry, launching solutions that offer improved thermal performance, enhanced sustainability, and greater operational efficiency. This includes the development of advanced smart packaging with better insulation, more reliable phase change materials, and integrated monitoring technologies. These product launches are aimed at addressing specific challenges in the supply chain, such as protecting high-value biologics or improving last-mile delivery. This focus on innovation helps companies differentiate themselves and capture a larger share of the expanding pharmaceutical packaging market.
What challenges does the Temperature Controlled Pharmaceutical Packaging Solutions Industry face during its growth?
- A significant challenge hindering industry growth is the lack of adequate logistics infrastructure and the slow adoption of automated technologies in key developing markets.
The lack of adequate logistics infrastructure and the slow adoption of automated technologies in certain developing economies present a significant challenge. Factors such as insufficient cold storage facilities, a scarcity of trained personnel, and unreliable power supplies impede the growth of a reliable cold chain. On average, approximately 20% of temperature-sensitive products are damaged due to breakdowns in the logistics supply chain. Furthermore, the high initial investment required for technologically advanced equipment discourages many warehousing service providers, especially smaller domestic companies, from upgrading their operations. This reliance on traditional methods limits service quality and constrains market growth in these regions.A lack of awareness regarding the benefits and availability of advanced temperature controlled pharmaceutical packaging solutions also impedes market growth. In some segments of the pharmaceutical industry, particularly among smaller companies or in emerging markets, there may be insufficient understanding of the critical importance of maintaining supply chain integrity for temperature-sensitive products. This can lead to the use of substandard packaging, increasing the risk of product spoilage and financial loss. Educating stakeholders about the value proposition of validated packaging solutions, including long-term cost savings from reduced product loss and enhanced regulatory compliance, is essential to overcoming this challenge and driving broader market adoption.
Exclusive Customer Landscape
The temperature controlled pharmaceutical packaging solutions market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the temperature controlled pharmaceutical packaging solutions market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, temperature controlled pharmaceutical packaging solutions market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Aeris Dynamics - The company provides a range of temperature controlled pharmaceutical packaging solutions. These offerings include various shipper series and specialized bio-pouches designed to maintain product integrity for temperature-sensitive goods during transit. The solutions cater to diverse needs within the pharmaceutical supply chain, ensuring compliance and safety for sensitive shipments.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Aeris Dynamics
- American Aerogel
- Cencora Inc.
- Cold Chain Technologies
- Cryo Store B.V.
- CSafe Global
- DGP Intelsius Ltd.
- DoKaSch GmbH
- DS Smith Plc
- Envirotainer AB
- FUCHS SE
- Hazgo
- Inmark Global Holdings LLC.
- Integreon Global
- Pelican Products Inc.
- Rapid Aid Corp.
- Sofrigam
- Sonoco Products Co.
- va Q tec Thermal Solutions GmbH
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Temperature Controlled Pharmaceutical Packaging Solutions Market
In May 2024, Sonoco launched EnviroFlex, a new pre-qualified temperature-controlled packaging solution designed to be fully recyclable.In February 2024, the delisting of va-Q-tec AG's shares was completed following its acquisition by EQT Private Equity and Mubadala.In January 2024, CSafe completed its acquisition of Kalibox, a French producer of passive temperature-controlled packaging, to expand its product portfolio and European presence.
Research Analyst Overview
The global temperature controlled pharmaceutical packaging solutions market is fundamentally shaped by the increasing complexity of temperature-sensitive pharmaceuticals within the global pharmaceutical supply chain. Effective cold chain logistics rely on a spectrum of solutions, from passive packaging systems using thermal insulation materials to advanced active packaging systems. These systems frequently incorporate insulated shipping containers enhanced with phase change materials and vacuum insulated panels to maintain biologic drug stability. Adherence to GDP is critical, mandating the use of validated packaging solutions. The integration of temperature data loggers and real-time temperature monitoring provides essential supply chain traceability, enabling continuous oversight and temperature excursion prevention throughout the biopharmaceutical shipping process, supported by infrastructure like reefer containers and refrigerated warehouses.The market's evolution is further driven by specialized logistical demands such as cell and gene therapy transport, which often necessitates cryogenic shipping and ultra-low temperature storage. The expansion of direct-to-patient shipping and complex clinical trial logistics has intensified the need for reliable last-mile delivery solutions. Concurrently, large-scale vaccine distribution logistics require robust thermal-controlled containers and insulated pallet shippers. Providers are developing both single-use packaging systems and reusable packaging solutions to cater to different operational needs, covering chilled product shipping, frozen product logistics, and even controlled ambient temperature packaging. The process of thermal packaging qualification is becoming more rigorous to meet these diverse applications, as the sector sees an annual expansion nearing 9% in its requirement for these advanced systems, including those using controlled-atmosphere technology.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Temperature Controlled Pharmaceutical Packaging Solutions Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
253
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 12.7%
|
|
Market growth 2024-2029
|
USD 5.9 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
11.9%
|
|
Key countries
|
US, Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, Argentina, Saudi Arabia, UAE, South Africa
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Temperature Controlled Pharmaceutical Packaging Solutions Market Research and Growth Report?
- CAGR of the Temperature Controlled Pharmaceutical Packaging Solutions industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, APAC, South America, Middle East and Africa
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the temperature controlled pharmaceutical packaging solutions market growth of industry companies
We can help! Our analysts can customize this temperature controlled pharmaceutical packaging solutions market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Temperature Controlled Pharmaceutical Packaging Solutions Market 2019 - 2023
- Historic Market Size - Data Table on Global Temperature Controlled Pharmaceutical Packaging Solutions Market 2019 - 2023 ($ billion)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 The impact of AI in global temperature controlled pharmaceutical packaging solutions market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Frozen - Market size and forecast 2024-2029
- Chart on Frozen - Market size and forecast 2024-2029 ($ billion)
- Data Table on Frozen - Market size and forecast 2024-2029 ($ billion)
- Chart on Frozen - Year-over-year growth 2024-2029 (%)
- Data Table on Frozen - Year-over-year growth 2024-2029 (%)
- 8.4 Chilled - Market size and forecast 2024-2029
- Chart on Chilled - Market size and forecast 2024-2029 ($ billion)
- Data Table on Chilled - Market size and forecast 2024-2029 ($ billion)
- Chart on Chilled - Year-over-year growth 2024-2029 (%)
- Data Table on Chilled - Year-over-year growth 2024-2029 (%)
- 8.5 Ambient - Market size and forecast 2024-2029
- Chart on Ambient - Market size and forecast 2024-2029 ($ billion)
- Data Table on Ambient - Market size and forecast 2024-2029 ($ billion)
- Chart on Ambient - Year-over-year growth 2024-2029 (%)
- Data Table on Ambient - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Type
- 9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 Passive systems - Market size and forecast 2024-2029
- Chart on Passive systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Passive systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Passive systems - Year-over-year growth 2024-2029 (%)
- Data Table on Passive systems - Year-over-year growth 2024-2029 (%)
- 9.4 Active systems - Market size and forecast 2024-2029
- Chart on Active systems - Market size and forecast 2024-2029 ($ billion)
- Data Table on Active systems - Market size and forecast 2024-2029 ($ billion)
- Chart on Active systems - Year-over-year growth 2024-2029 (%)
- Data Table on Active systems - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by End-user
- 10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Pharmaceuticals - Market size and forecast 2024-2029
- Chart on Pharmaceuticals - Market size and forecast 2024-2029 ($ billion)
- Data Table on Pharmaceuticals - Market size and forecast 2024-2029 ($ billion)
- Chart on Pharmaceuticals - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceuticals - Year-over-year growth 2024-2029 (%)
- 10.4 Vaccines and biologics - Market size and forecast 2024-2029
- Chart on Vaccines and biologics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Vaccines and biologics - Market size and forecast 2024-2029 ($ billion)
- Chart on Vaccines and biologics - Year-over-year growth 2024-2029 (%)
- Data Table on Vaccines and biologics - Year-over-year growth 2024-2029 (%)
- 10.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.5 APAC - Market size and forecast 2024-2029
- Chart on APAC - Market size and forecast 2024-2029 ($ billion)
- Data Table on APAC - Market size and forecast 2024-2029 ($ billion)
- Chart on APAC - Year-over-year growth 2024-2029 (%)
- Data Table on APAC - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - APAC
- Data Table on Regional Comparison - APAC
- 12.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.5.2 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.5.3 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.6 South America - Market size and forecast 2024-2029
- Chart on South America - Market size and forecast 2024-2029 ($ billion)
- Data Table on South America - Market size and forecast 2024-2029 ($ billion)
- Chart on South America - Year-over-year growth 2024-2029 (%)
- Data Table on South America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - South America
- Data Table on Regional Comparison - South America
- 12.6.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.2 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 12.7 Middle East and Africa - Market size and forecast 2024-2029
- Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Middle East and Africa
- Data Table on Regional Comparison - Middle East and Africa
- 12.7.1 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.7.2 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.7.3 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growth in demand for reefer containers from pharmaceutical industry
- Increase in number of refrigerated warehouses
- Increase in global demand for pharmaceuticals
- 13.2 Market challenges
- Lack of logistics infrastructure and low adoption of automated technologies
- Lack of awareness regarding temperature controlled pharmaceutical packaging solutions
- Increase in operational costs due to functional barriers in cold chain logistics
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Growing focus on traditional strategies like acquisition by market companies
- Growing number of temperature controlled pharmaceutical packaging product launches by market companies
- Rising popularity of blockchain and artificial intelligence technology in logistics industry
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Aeris Dynamics
- Aeris Dynamics - Overview
- Aeris Dynamics - Product / Service
- Aeris Dynamics - Key offerings
- SWOT
- 15.5 American Aerogel
- American Aerogel - Overview
- American Aerogel - Product / Service
- American Aerogel - Key offerings
- SWOT
- 15.6 Cold Chain Technologies
- Cold Chain Technologies - Overview
- Cold Chain Technologies - Product / Service
- Cold Chain Technologies - Key offerings
- SWOT
- 15.7 Cryo Store B.V.
- Cryo Store B.V. - Overview
- Cryo Store B.V. - Product / Service
- Cryo Store B.V. - Key offerings
- SWOT
- 15.8 DGP Intelsius Ltd.
- DGP Intelsius Ltd. - Overview
- DGP Intelsius Ltd. - Product / Service
- DGP Intelsius Ltd. - Key offerings
- SWOT
- 15.9 DoKaSch GmbH
- DoKaSch GmbH - Overview
- DoKaSch GmbH - Product / Service
- DoKaSch GmbH - Key offerings
- SWOT
- 15.10 DS Smith Plc
- DS Smith Plc - Overview
- DS Smith Plc - Business segments
- DS Smith Plc - Key news
- DS Smith Plc - Key offerings
- DS Smith Plc - Segment focus
- SWOT
- 15.11 Envirotainer AB
- Envirotainer AB - Overview
- Envirotainer AB - Product / Service
- Envirotainer AB - Key offerings
- SWOT
- 15.12 FUCHS SE
- FUCHS SE - Overview
- FUCHS SE - Business segments
- FUCHS SE - Key news
- FUCHS SE - Key offerings
- FUCHS SE - Segment focus
- SWOT
- 15.13 Hazgo
- Hazgo - Overview
- Hazgo - Product / Service
- Hazgo - Key offerings
- SWOT
- 15.14 Inmark Global Holdings LLC.
- Inmark Global Holdings LLC. - Overview
- Inmark Global Holdings LLC. - Product / Service
- Inmark Global Holdings LLC. - Key offerings
- SWOT
- 15.15 Integreon Global
- Integreon Global - Overview
- Integreon Global - Product / Service
- Integreon Global - Key offerings
- SWOT
- 15.16 Pelican Products Inc.
- Pelican Products Inc. - Overview
- Pelican Products Inc. - Product / Service
- Pelican Products Inc. - Key offerings
- SWOT
- 15.17 Rapid Aid Corp.
- Rapid Aid Corp. - Overview
- Rapid Aid Corp. - Product / Service
- Rapid Aid Corp. - Key offerings
- SWOT
- 15.18 Sofrigam
- Sofrigam - Overview
- Sofrigam - Product / Service
- Sofrigam - Key offerings
- SWOT
- 15.19 Sonoco Products Co.
- Sonoco Products Co. - Overview
- Sonoco Products Co. - Business segments
- Sonoco Products Co. - Key news
- Sonoco Products Co. - Key offerings
- Sonoco Products Co. - Segment focus
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
